Nau Jeffrey

CIK 00017911591 companyPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001791159

Recent Transactions

30 trades

Disposition to Issuer
Oyster Point Pharma, Inc.
Performance Stock Units
2023-01-03−350,000→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−434,774→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−116,539→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−387,151→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−211,533→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−210,000→ 0 total
Disposition from Tender
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−100,738→ 47,975 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−1,000→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−11,031→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−47,975→ 0 total
Tax Payment
Oyster Point Pharma, Inc.
Common Stock
2022-12-01$11.20/sh−8,938→ 148,660 total
Tax Payment
Oyster Point Pharma, Inc.
Common Stock
2022-12-01$11.20/sh−6,217→ 151,381 total
Award
Oyster Point Pharma, Inc.
Performance Stock Units
2022-07-06+350,000→ 350,000 total
Tax Payment
Oyster Point Pharma, Inc.
Common Stock
2022-01-29$11.70/sh−2,607→ 148,713 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2022-01-09+210,000→ 210,000 total
Award
Oyster Point Pharma, Inc.
Common Stock
2022-01-09+46,700→ 157,598 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-10-21−50,000→ 434,774 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Common Stock
2021-10-21$1.02/sh+50,000→ 110,898 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Common Stock
2021-09-01$1.02/sh+10,000→ 60,898 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-09-01−10,000→ 484,774 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-04-02−10,000→ 494,774 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Common Stock
2021-04-02$1.02/sh+10,000→ 50,898 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Common Stock
2021-02-19$1.02/sh+10,000→ 40,898 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-02-19−10,000→ 504,774 total
Award
Oyster Point Pharma, Inc.
Common Stock
2021-01-29+25,898→ 30,898 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2021-01-29+116,539→ 116,539 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Common Stock
2020-07-28$1.02/sh+5,000→ 5,000 total
Exercise/Conversion
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2020-07-28−5,000→ 514,774 total
Award
Oyster Point Pharma, Inc.
Employee Stock Option (Right to Buy)
2020-02-03+211,533→ 211,533 total
Purchase
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+1,000→ 1,000 total

Companies

Oyster Point Pharma, Inc.
Director, President and CEO

Recent Filings

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540

View on SEC.gov